Cargando…
A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city()()
OBJECTIVES: Despite several publications on the analytical performance of high-sensitivity cardiac troponin (hs-cTn) assays, there has been little information on how laboratories should validate and implement these assays into clinical service. Our study provides a practical approach for the validat...
Autores principales: | Kavsak, Peter A., Beattie, John, Pickersgill, Robin, Ford, Lynn, Caruso, Nadia, Clark, Lorna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597710/ https://www.ncbi.nlm.nih.gov/pubmed/28932796 http://dx.doi.org/10.1016/j.plabm.2015.02.001 |
Ejemplares similares
-
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency Setting
por: Kavsak, Peter A., et al.
Publicado: (2021) -
High-Sensitivity Cardiac Troponin Publications during the COVID-19 Pandemic (2020–2022)
por: Kavsak, Peter A.
Publicado: (2022) -
Combination of lymphocyte count and not the serological response with high-sensitivity cardiac troponin for risk stratification in patients with possible COVID-19
por: Kittanakom, Saranya, et al.
Publicado: (2021)